Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019
Abstract Background Women suffering from severe nausea and vomiting during pregnancy, hyperemesis gravidarum, have poor quality of life and increased risk of potentially fatal maternal and fetal complications. There is increasing and reassuring knowledge about safety of antiemetics in pregnancy. In...
Main Authors: | Hilde Erdal, Lone Holst, Kristine Heitmann, Jone Trovik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12884-022-04777-x |
Similar Items
-
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT
by: Stephen Robson, et al.
Published: (2021-11-01) -
Prevalence of Helicobacter Pylori Infection in Pregnant Women with Hyperemesis Gravidarum
by: Mohammad AM Ahmed *, et al.
Published: (2023-07-01) -
Risk Factors for Infusions, Emergency Room Visits and Hospitalizations for Hyperemesis Gravidarum: New Data and Literature Review
by: de Vera SA, et al.
Published: (2024-10-01) -
What do repetitive thinking styles tell about hyperemesis gravidarum?
by: Fatih Yavuz, et al.
Published: (2018-04-01) -
Risk Factors of Prolonged Hospitalization in Patients with Hyperemesis Gravidarum
by: Hasan Onur Topcu, et al.
Published: (2015-03-01)